Revolution Medicines (RVMD) Other Gross PP&E Adjustments (2019 - 2026)
Revolution Medicines has reported Other Gross PP&E Adjustments over the past 7 years, most recently at -$103.8 million for Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments fell 13.31% year-over-year to -$103.8 million; the TTM value through Dec 2025 reached -$103.8 million, down 13.31%, while the annual FY2025 figure was -$103.8 million, 13.31% down from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 was -$103.8 million at Revolution Medicines, down from -$76.9 million in the prior quarter.
- Over five years, Other Gross PP&E Adjustments peaked at $8.4 million in Q1 2023 and troughed at -$103.8 million in Q4 2025.
- A 5-year average of -$37.5 million and a median of -$31.2 million in 2024 define the central range for Other Gross PP&E Adjustments.
- Biggest five-year swings in Other Gross PP&E Adjustments: surged 124.02% in 2023 and later plummeted 524.42% in 2024.
- Year by year, Other Gross PP&E Adjustments stood at -$41.2 million in 2021, then increased by 29.57% to -$29.0 million in 2022, then tumbled by 60.26% to -$46.5 million in 2023, then plummeted by 97.23% to -$91.6 million in 2024, then fell by 13.31% to -$103.8 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for RVMD at -$103.8 million in Q4 2025, -$76.9 million in Q3 2025, and -$58.8 million in Q2 2025.